Selection for hepatic resection of colorectal liver metastases: Expert consensus statement

HPB

Volumn 15, Issue 2, 2013, Pages 91-103

  Adams, Reid B ^a   Aloia, Thomas A ^b   Loyer, Evelyne ^b   Pawlik, Timothy M ^c   Taouli, Bachir ^d   Vauthey, Jean Nicolas ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CONTRAST MEDIUM; GADOBENIC ACID; GADOLINIUM PENTETATE MEGLUMINE; GADOXETIC ACID; PERFLUBUTANE;

ARTICLE; BILIARY TRACT DRAINAGE; CANCER CHEMOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FUNCTION; LIVER METASTASIS; LIVER PERFUSION; LIVER RESECTION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 84872185425     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00557.x     Document Type: Article

References (136)

1. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA,. (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13: 1261-1268. Epub 2006/09/02. (Pubitemid 44435791)
2. Konopke R, Kersting S, Bergert H, Bloomenthal A, Gastmeier J, Saeger HD, et al. (2007) Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 22: 201-207.
3. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A, et al. (2006) Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 12: 1699-1705. Epub 2006/04/06.
4. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, et al. (2007) The value of contrast enhanced ultrasonography in detection of liver metastases from colorectal cancer: A prospective double-blinded study. Eur J Radiol 62: 302-307. (Pubitemid 46560336)
5. Sugimoto K, Shiraishi J, Moriyasu F, Saito K, Doi K,. (2009) Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis. Acad Radiol 16: 798-809. Epub 2009/04/28.
6. Hatanaka K, Kudo M, Minami Y, Maekawa K,. (2008) Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 75 (Suppl. 1): 42-47. Epub 2009/02/20.
7. Moriyasu F, Itoh K,. (2009) Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol 193: 86-95. Epub 2009/06/23.
8. Cervone A, Sardi A, Conaway GL,. (2000) Intraoperative ultrasound (IOUS) is essential in the management of metastatic colorectal liver lesions. Am Surg 66: 611-615. Epub 2000/08/05. (Pubitemid 30457755)
9. Foroutani A, Garland AM, Berber E, String A, Engle K, Ryan TL, et al. (2000) Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg 135: 933-938. Epub 2000/08/02. (Pubitemid 30625971)
10. Kruskal JB, Kane RA,. (2006) Intraoperative US of the liver: techniques and clinical applications. Radiographics 26: 1067-1084. Epub 2006/07/18. (Pubitemid 44180878)
11. Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA,. (2006) Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol 13: 542-546. Epub 2006/02/14.
12. Ellsmere J, Kane R, Grinbaum R, Edwards M, Schneider B, Jones D,. (2007) Intraoperative ultrasonography during planned liver resections: why are we still performing it? Surg Endosc 21: 1280-1283. Epub 2007/02/13. (Pubitemid 47125056)
13. Sahani DV, Kalva SP, Tanabe KK, Hayat SM, O'Neill MJ, Halpern EF, et al. (2004) Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology 232: 810-814. Epub 2004/07/27. (Pubitemid 39100267)
14. Tamandl D, Herberger B, Gruenberger B, Schoppmann SF, Puhalla H, Schindl M, et al. (2008) Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery 143: 648-657. Epub 2008/04/26.
15. Ong KO, Leen E,. (2007) Radiological staging of colorectal liver metastases. Surg Oncol 16: 7-14. Epub 2007/05/15. (Pubitemid 46880336)
16. Kamel IR, Fishman EK,. (2004) Recent advances in CT imaging of liver metastases. Cancer J. 10: 104-120. (Pubitemid 44403476)
17. Soyer P, Poccard M, Boudiaf M, Abitbol M, Hamzi L, Panis Y, et al. (2004) Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology 231: 413-420. (Pubitemid 38552898)
18. Scatarige JC, Fishman EK, Saksouk FA, Siegelman SS,. (1983) Computed tomography of calcified liver masses. J Comput Assist Tomogr 7: 83-89. Epub 1983/02/01. (Pubitemid 13189441)
19. Khalil HI, Patterson SA, Panicek DM,. (2005) Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 235: 872-878. (Pubitemid 40695883)
20. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM,. (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210: 71-74. Epub 1999/01/14. (Pubitemid 29004285)
21. Braga L, Guller U, Semelka RC,. (2004) Modern hepatic imaging. Surg Clin North Am 84: 375-400. Epub 2004/04/06. (Pubitemid 38388273)
22. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B,. (2010) Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 31: 589-600. Epub 2010/02/27.
23. Semelka RC, Cance WG, Marcos HB, Mauro MA,. (1999) Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 213: 86-91. Epub 1999/11/30. (Pubitemid 29470410)
24. Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, et al. (1999) Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212: 876-884. (Pubitemid 29410996)
25. Pedro MS, Semelka RC, Braga L,. (2002) MR imaging of hepatic metastases. Magn Reson Imaging Clin N Am 10: 15-29. Epub 2002/05/10. (Pubitemid 34205579)
26. Danet IM, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, et al. (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181: 809-817. (Pubitemid 37021860)
27. Semelka RC, Hussain SM, Marcos HB, Woosley JT,. (2000) Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings-initial observations. Radiology 215: 89-94. Epub 2001/02/07. (Pubitemid 30190515)
28. Bruegel M, Gaa J, Waldt S, Woertler K, Holzapfel K, Kiefer B, et al. (2008) Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 191: 1421-1429.
29. Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, et al. (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246: 812-822. Epub 2008/01/29.
30. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB,. (2006) MR contrast agents for liver imaging: what, when, how. Radiographics 26: 1621-1636.
31. Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, et al. (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18: 457-467. Epub 2007/12/07. (Pubitemid 351248177)
32. Kim YK, Lee JM, Kim CS, Chung GH, Kim CY, Kim IH,. (2005) Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 15: 220-228.
33. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K,. (2010) Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 20: 2690-2698. Epub 2010/06/22.
34. Lowenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, et al. (2011) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21: 832-840. Epub 2010/10/05.
35. Koh DM, Brown G, Riddell AM, Scurr E, Collins DJ, Allen SD, et al. (2008) Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol 18: 903-910. Epub 2008/01/15.
36. Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM,. (2011) Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol 85: 980-989.
37. Erturk SM, Ichikawa T, Fujii H, Yasuda S, Ros PR,. (2006) PET imaging for evaluation of metastatic colorectal cancer of the liver. Eur J Radiol 58: 229-235.
38. Chen LB, Tong JL, Song HZ, Zhu H, Wang YC,. (2007) (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 13: 5025-5029. Epub 2007/09/15. (Pubitemid 47496838)
39. Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, et al. (2007) The impact of 18F-FDG PET/CT in patients with liver metastases. Eur J Nucl Med Mol Imaging 34: 1906-1914. Epub 2007/08/24. (Pubitemid 350212127)
40. Schmidt GP, Baur-Melnyk A, Haug A, Utzschneider S, Becker CR, Tiling R, et al. (2009) Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19: 1366-1378. Epub 2009/02/05.
41. Truant S, Huglo D, Hebbar M, Ernst O, Steinling M, Pruvot FR,. (2005) Prospective evaluation of the impact of [18F]fluoro-2-deoxy-D-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92: 362-369. Epub 2005/01/27. (Pubitemid 40445601)
42. Votrubova J, Belohlavek O, Jaruskova M, Oliverius M, Lohynska R, Trskova K, et al. (2006) The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 33: 779-784. Epub 2006/03/28. (Pubitemid 43979685)
43. Badiee S, Franc BL, Webb EM, Chu B, Hawkins RA, Coakley F,. (2008) Role of IV iodinated contrast material in 18F-FDG PET/CT of liver metastases. AJR Am J Roentgenol 191: 1436-1439.
44. Glazer ES, Beaty K, Abdalla EK, Vauthey JN, Curley SA,. (2010) Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Arch Surg 145: 340-345; discussion 345. Epub 2010/04/21.
45. Floriani I, Torri V, Rulli E, Garavaglia D, Compagnoni A, Salvolini L, et al. (2010) Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta-analysis. J Magn Reson Imaging 31: 19-31. Epub 2009/12/23.
46. Niekel MC, Bipat S, Stoker J,. (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: A meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257: 674-684. Epub 2010/09/11.
47. Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE,. (2011) Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Invest Radiol 46: 548-555. Epub 2011/05/18.
48. Kulemann V, Schima W, Tamandl D, Kaczirek K, Gruenberger T, Wrba F, et al. (2011) Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? Eur J Radiol 79: e1-e6. Epub 2010/04/16.
49. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216.
50. Jaffe CC,. (2006) Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 24: 3245-3251. Epub 2006/07/11. (Pubitemid 46622065)
51. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247. Epub 2008/12/23.
52. Figueiras RG, Goh V, Padhani AR, Naveira AB, Caamano AG, Martin CV,. (2010) The role of functional imaging in colorectal cancer. AJR Am J Roentgenol 195: 54-66. Epub 2010/06/23.
53. Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: A randomized phase III study. J Clin Oncol 26: 2013-2019. Epub 2008/04/19.
54. Taouli B, Koh DM,. (2010) Diffusion-weighted MR imaging of the liver. Radiology 254: 47-66. Epub 2009/12/25.
55. Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA,. (2011) Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 261: 165-171. Epub 2011/08/05.
56. Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR,. (2008) Chemoembolization of hepatic metastases from ocular melanoma: Assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol 191: 285-289. Epub 2008/06/20. (Pubitemid 351955216)
57. Cui Y, Zhang XP, Sun YS, Tang L, Shen L,. (2008) Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 248: 894-900. Epub 2008/08/20.
58. Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, et al. (2007) Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 188: 1001-1008. Epub 2007/03/23. (Pubitemid 46496932)
59. Benoist S, Brouquet A, Penna C, Julie C, El Hajjam M, Chagnon S, et al. (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24: 3939-3945. Epub 2006/08/22. (Pubitemid 46630742)
60. De Roock W, Piessevaux H, De Schutter J, Janssens M, De Hertogh G, Personeni N, et al. (2008) KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol 19: 508-515. Epub 2007/11/14. (Pubitemid 351325672)
61. Suzuki C, Blomqvist L, Sundin A, Jacobsson H, Bystrom P, Berglund A, et al. (2012) The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy. Ann Oncol 23: 948-954. Epub 2011/08/13.
62. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, et al. (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25: 1753-1759. Epub 2007/05/02. (Pubitemid 46797957)
63. Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302: 2338-2344. Epub 2009/12/03.
64. de Geus-Oei LF, Vriens D, van, Laarhoven HW, van der, Graaf WT, Oyen WJ,. (2009) Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: A systematic review. J Nucl Med 50 (Suppl. 1): 43S-54S. Epub 2009/06/24.
65. Bystrom P, Berglund A, Garske U, Jacobsson H, Sundin A, Nygren P, et al. (2009) Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer. Ann Oncol 20: 1057-1061. Epub 2009/01/24.
66. Tan MC, Linehan DC, Hawkins WG, Siegel BA, Strasberg SM,. (2007) Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response. J Gastrointest Surg 11: 1112-1119. Epub 2007/07/12.
67. Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, et al. (2011) Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy. Ann Oncol 23: 1687-1693.
68. Elias D, Liberale G, Vernerey D, Pocard M, Ducreux M, Boige V, et al. (2005) Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12: 900-909. (Pubitemid 41504223)
69. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P,. (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90: 567-574. Epub 2003/05/08. (Pubitemid 36577888)
70. Jaeck D, Nakano H, Bachellier P, Inoue K, Weber JC, Oussoultzoglou E, et al. (2002) Significance of hepatic pedicle lymph node involvement in patients with colorectal liver metastases: A prospective study. Ann Surg Oncol 9: 430-438. (Pubitemid 34625801)
71. Carpizo DR, Are C, Jarnagin W, Dematteo R, Fong Y, Gonen M, et al. (2009) Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol 16: 2138-2146. Epub 2009/06/06.
72. Pulitano C, Bodingbauer M, Aldrighetti L, de, Jong MC, Castillo F, Schulick RD, et al. (2011) Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 18: 1380-1388. Epub 2010/12/08.
73. Adam R, de Haas RJ, Wicherts DA, Vibert E, Salloum C, Azoulay D, et al. (2011) Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg 253: 349-359. Epub 2010/12/24.
74. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al. (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28: 63-68. Epub 2009/11/18.
75. Chua TC, Saxena A, Liauw W, Chu F, Morris DL,. (2011) Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases-a systematic review. Eur J Cancer 48: 1757-1765.
76. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial. Lancet 371: 1007-1016. (Pubitemid 351392040)
77. Allen PJ, Kemeny N, Jarnagin W, DeMatteo R, Blumgart L, Fong Y,. (2003) Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7: 109-115; discussion 116-117.
78. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. (2004) Tumor progression while on chemotherapy: A contraindication to liver resection for multiple colorectal metastases? Ann Surg 240: 1052-1061; discussion 1061-1064.
79. Neumann UP, Thelen A, Rocken C, Seehofer D, Bahra M, Riess H, et al. (2009) Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases. Surgery 146: 52-59. Epub 2009/06/23.
80. Adam R, Aloia T, Levi F, Wicherts DA, de, Haas RJ, Paule B, et al. (2007) Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 25: 4593-4602. Epub 2007/10/11. (Pubitemid 350035318)
81. Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN,. (2004) Total and segmental liver volume variations: implications for liver surgery. Surgery 135: 404-410. (Pubitemid 38453495)
82. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127: 512-519. (Pubitemid 30257509)
83. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 107: 521-527. (Pubitemid 20156653)
84. Uesaka K, Nimura Y, Nagino M,. (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223: 77-83. (Pubitemid 26030035)
85. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN,. (2007) Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94: 1386-1394. (Pubitemid 350144388)
86. Wicherts DA, de Haas RJ, Andreani P, Sotirov D, Salloum C, Castaing D, et al. (2010) Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 97: 240-250. Epub 2010/01/21.
87. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26: 1176-1181. (Pubitemid 27509300)
88. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN,. (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137: 675-680; discussion 680-681.
89. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237: 208-217. (Pubitemid 38173248)
90. Abdalla EK, Hicks ME, Vauthey JN,. (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88: 165-175. (Pubitemid 32142701)
91. Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, et al. (2004) Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 239: 722-730; discussion 730-732.
92. Imamura H, Sano K, Sugawara Y, Kokudo N, Makuuchi M,. (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12: 16-22. Epub 2005/03/09. (Pubitemid 40378835)
93. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC,. (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243: 373-379. Epub 2006/02/24. (Pubitemid 43327770)
94. Aloia T, Sebagh M, Plasse M, Karam V, Levi F, Giacchetti S, et al. (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24: 4983-4990. (Pubitemid 46631400)
95. Balzan S, Nagarajan G, Farges O, Galleano CZ, Dokmak S, Paugam C, et al. (2010) Safety of liver resections in obese and overweight patients. World J Surg 34: 2960-2968. Epub 2010/08/17.
96. El-Serag HB, Mason AC,. (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750. Epub 1999/03/11. (Pubitemid 29114292)
97. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg 247: 125-135. Epub 2007/12/25.
98. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77: 1254-1262. (Pubitemid 26102322)
99. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH,. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321.
100. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S,. (2006) Survival after hepatic resection for colorectal metastases: A 10-year experience. Ann Surg Oncol 13: 668-676. Epub 2006/03/09.
101. Kato T, Yasui K, Hirai T, Kanemitsu Y, Mori T, Sugihara K, et al. (2003) Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: Analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46 (10 Suppl.): S22-S31. Epub 2003/10/08. (Pubitemid 37266357)
102. Scheele J, Altendorf-Hofmann A, Grube T, Hohenberger W, Stangl R, Schmidt K,. (2001) Resektion colorectaler Lebermetastasen. Welche Prognosefaktoren bestimmen die Patientenselektion? [Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg 72: 547-560. Epub 2001/06/01. (Pubitemid 33678653)
103. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al. (2011) High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 29: 1083-1090. Epub 2011/01/26.
104. Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P, et al. (2003) One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185: 221-229. Epub 2003/03/07. (Pubitemid 36298887)
105. Aloia TA, Vauthey JN,. (2011) Management of colorectal liver metastases: past, present, and future. Updates Surg 63: 1-3. Epub 2011/02/19.
106. de Santibanes E, Alvarez FA, Ardiles V,. (2012) How to avoid postoperative liver failure: A novel method. World J Surg 36: 125-128. Epub 2011/11/03.
107. Torzilli G, Donadon M, Palmisano A, Marconi M, Procopio F, Botea F, et al. (2009) Ultrasound guided liver resection: does this approach limit the need for portal vein embolization? Hepatogastroenterology 56: 1483-1490. Epub 2009/12/03.
108. Torzilli G, Procopio F, Botea F, Marconi M, Del Fabbro D, Donadon M, et al. (2009) One-stage ultrasonographically guided hepatectomy for multiple bilobar colorectal metastases: A feasible and effective alternative to the 2-stage approach. Surgery 146: 60-71. Epub 2009/06/23.
109. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG, et al. (1986) Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100: 278-284. Epub 1986/08/01. (Pubitemid 16070861)
110. Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, et al. (1997) Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84: 1077-1080. Epub 1997/08/01. (Pubitemid 27359477)
111. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. (1997) Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 84: 977-980. Epub 1997/07/01. (Pubitemid 27310867)
112. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241: 715-722; discussion 722-724. Epub 2005/04/26.
113. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP,. (2006) Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1cm rule. Eur J Surg Oncol 32: 557-563. Epub 2006/04/04.
114. Lordan JT, Karanjia ND,. (2010) 'Close shave' in liver resection for colorectal liver metastases. Eur J Surg Oncol 36: 47-51. Epub 2009/06/09.
115. Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S, et al. (2007) Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 18: 1190-1195. Epub 2007/04/17. (Pubitemid 47244365)
116. Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L,. (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17: 1324-1329. Epub 2009/10/23.
117. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. (2002) Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 137: 833-840. Epub 2002/07/03. (Pubitemid 34743176)
118. Ng JK, Urbanski SJ, Mangat N, McKay A, Sutherland FR, Dixon E, et al. (2008) Colorectal liver metastases contract centripetally with a response to chemotherapy: A histomorphologic study. Cancer 112: 362-371.
119. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R,. (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248: 626-637. Epub 2008/10/22.
120. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 240: 644-657; discussion 657-658. Epub 2004/09/24.
121. Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vauthey JN, et al. (2000) Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7: 490-495. Epub 2000/08/18. (Pubitemid 30666487)
122. Auer RC, White RR, Kemeny NE, Schwartz LH, Shia J, Blumgart LH, et al. (2010) Predictors of a true complete response among disappearing liver metastases from colorectal cancer after chemotherapy. Cancer 116: 1502-1509. Epub 2010/02/02.
123. Blazer DG, 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, et al. (2008) Pathologic response to preoperative chemotherapy: A new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26: 5344-5351.
124. Elias D, Youssef O, Sideris L, Dromain C, Baton O, Boige V, et al. (2004) Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy. J Surg Oncol 86: 4-9. Epub 2004/03/30. (Pubitemid 38490093)
125. Elias D, Goere D, Boige V, Kohneh-Sharhi N, Malka D, Tomasic G, et al. (2007) Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann Surg Oncol 14: 3188-3194. Epub 2007/08/21. (Pubitemid 47594272)
126. Tanaka K, Takakura H, Takeda K, Matsuo K, Nagano Y, Endo I,. (2009) Importance of complete pathologic response to prehepatectomy chemotherapy in treating colorectal cancer metastases. Ann Surg 250: 935-942. Epub 2009/12/03.
127. van Vledder MG, de Jong MC, Pawlik TM, Schulick RD, Diaz LA, Choti MA,. (2010) Disappearing colorectal liver metastases after chemotherapy: should we be concerned? J Gastrointest Surg 14: 1691-1700. Epub 2010/09/15.
128. Zalinski S, Abdalla EK, Mahvash A, Vauthey JN,. (2009) A marking technique for intraoperative localization of small liver metastases before systemic chemotherapy. Ann Surg Oncol 16: 1208-1211. Epub 2009/02/14.
129. Gaujoux S, Goere D, Dumont F, Souadka A, Dromain C, Ducreux M, et al. (2011) Complete radiological response of colorectal liver metastases after
130. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, et al. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237: 123-131. (Pubitemid 41346155)
131. Regge D, Campanella D, Anselmetti GC, Cirillo S, Gallo TM, Muratore A, et al. (2006) Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 61: 338-347. Epub 2006/03/21.
132. van Kessel CS, van Leeuwen MS, van den Bosch MA, Borel Rinkes IH, Mali WP, Westers P, et al. (2011) Accuracy of multislice liver CT and MRI for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy. Dig Surg 28: 36-43. Epub 2011/02/05.
133. Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK,. (1998) Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 77: 2008-2011. (Pubitemid 28254648)
134. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072. (Pubitemid 46622116)
135. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA,. (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11: 860-868.
136. Chami L, Lassau N, Malka D, Ducreux M, Bidault S, Roche A, et al. (2008) Benefits of contrast-enhanced sonography for the detection of liver lesions: comparison with histologic findings. AJR Am J Roentgenol 190: 683-690. Epub 2008/02/22. (Pubitemid 351304512)